Literature DB >> 16464906

Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content.

Clinton R Bruce1, A Brianne Thrush, Valerie A Mertz, Veronic Bezaire, Adrian Chabowski, George J F Heigenhauser, David J Dyck.   

Abstract

Muscle fatty acid (FA) metabolism is impaired in obesity and insulin resistance, reflected by reduced rates of FA oxidation and accumulation of lipids. It has been suggested that interventions that increase FA oxidation may enhance insulin action by reducing these lipid pools. Here, we examined the effect of endurance training on rates of mitochondrial FA oxidation, the activity of carnitine palmitoyltransferase I (CPT I), and the lipid content in muscle of obese individuals and related these to measures of glucose tolerance. Nine obese subjects completed 8 wk of moderate-intensity endurance training, and muscle biopsies were obtained before and after training. Training significantly improved glucose tolerance, with a reduction in the area under the curve for glucose (P < 0.05) and insulin (P = 0.01) during an oral glucose tolerance test. CPT I activity increased 250% (P = 0.001) with training and became less sensitive to inhibition by malonyl-CoA. This was associated with an increase in mitochondrial FA oxidation (+120%, P < 0.001). Training had no effect on muscle triacylglycerol content; however, there was a trend for training to reduce both the total diacylglcyerol (DAG) content (-15%, P = 0.06) and the saturated DAG-FA species (-27%, P = 0.06). Training reduced both total ceramide content (-42%, P = 0.01) and the saturated ceramide species (-32%, P < 0.05). These findings suggest that the improved capacity for mitochondrial FA uptake and oxidation leads not only to a reduction in muscle lipid content but also a to change in the saturation status of lipids, which may, at least in part, provide a mechanism for the enhanced insulin action observed with endurance training in obese individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464906     DOI: 10.1152/ajpendo.00587.2005

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  102 in total

1.  Training in the fasted state improves glucose tolerance during fat-rich diet.

Authors:  Karen Van Proeyen; Karolina Szlufcik; Henri Nielens; Koen Pelgrim; Louise Deldicque; Matthijs Hesselink; Paul P Van Veldhoven; Peter Hespel
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

2.  Short-term effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects.

Authors:  C Lawrence Kien; Karen I Everingham; Robert D Stevens; Naomi K Fukagawa; Deborah M Muoio
Journal:  Obesity (Silver Spring)       Date:  2010-06-17       Impact factor: 5.002

Review 3.  Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity.

Authors:  Maximilian J Schloss; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

4.  Mitochondrial function: use it or lose it.

Authors:  J A Hawley; S J Lessard
Journal:  Diabetologia       Date:  2007-04       Impact factor: 10.122

Review 5.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

6.  Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes.

Authors:  Bryan C Bergman; Leigh Perreault; Devon M Hunerdosse; Mary C Koehler; Ali M Samek; Robert H Eckel
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

Review 7.  Skeletal muscle insulin resistance: roles of fatty acid metabolism and exercise.

Authors:  Lorraine P Turcotte; Jonathan S Fisher
Journal:  Phys Ther       Date:  2008-09-18

8.  Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle.

Authors:  Graham P Holloway; Jamie Lally; James G Nickerson; Hakam Alkhateeb; Laelie A Snook; George J F Heigenhauser; Jorge Calles-Escandon; Jan F C Glatz; Joost J F P Luiken; Lawrence L Spriet; Arend Bonen
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

9.  Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity.

Authors:  M Skovbro; M Baranowski; C Skov-Jensen; A Flint; F Dela; J Gorski; J W Helge
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

Review 10.  Lipotoxicity as a trigger factor of renal disease.

Authors:  Adriana Izquierdo-Lahuerta; Cristina Martínez-García; Gema Medina-Gómez
Journal:  J Nephrol       Date:  2016-03-08       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.